Clinical trials
Phase 2 Lupus Erythematosus, Systemic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| MedImmune LLC | 2 |
| Pfizer | 2 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Celgene | 1 |
| GlaxoSmithKline | 1 |
| Human Genome Sciences Inc. | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 21 |
| Lupus Nephritis | 2 |
| Arthritis, Rheumatoid | 1 |
| Lupus Erythematosus, Cutaneous | 1 |
| Lupus Erythematosus, Discoid | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.